ORPEA (ORP.PA)
FR001400NLM4 - Common Stock
ORP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 23 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ORP have multiple concerns. While showing a medium growth rate, ORP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ORP has reported negative net income.
ORP had a positive operating cash flow in the past year.
ORP had positive earnings in 4 of the past 5 years.
ORP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ORP has a worse Return On Assets (-27.42%) than 95.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.42% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-8.82%
ROA(5y)-4.57%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ORP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ORP has about the same amount of shares outstanding.
ORP has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, ORP has a worse debt to assets ratio.
2.2 Solvency
ORP has an Altman-Z score of -0.67. This is a bad value and indicates that ORP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ORP (-0.67) is worse than 86.96% of its industry peers.
The Debt to FCF ratio of ORP is 27.09, which is on the high side as it means it would take ORP, 27.09 years of fcf income to pay off all of its debts.
ORP has a worse Debt to FCF ratio (27.09) than 73.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 27.09 | ||
| Altman-Z | -0.67 |
ROIC/WACCN/A
WACC4.71%
2.3 Liquidity
ORP has a Current Ratio of 0.17. This is a bad value and indicates that ORP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.17, ORP is doing worse than 95.65% of the companies in the same industry.
A Quick Ratio of 0.16 indicates that ORP may have some problems paying its short term obligations.
ORP has a worse Quick ratio (0.16) than 95.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.17 | ||
| Quick Ratio | 0.16 |
3. Growth
3.1 Past
ORP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6733.33%.
Looking at the last year, ORP shows a quite strong growth in Revenue. The Revenue has grown by 8.89% in the last year.
Measured over the past years, ORP shows a quite strong growth in Revenue. The Revenue has been growing by 8.33% on average per year.
EPS 1Y (TTM)-6733.33%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-37.04%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y7.76%
Revenue growth 5Y8.33%
Revenue growth Q2Q10.67%
3.2 Future
The Earnings Per Share is expected to grow by 26.00% on average over the next years. This is a very strong growth
Based on estimates for the next years, ORP will show a small growth in Revenue. The Revenue will grow by 7.93% on average per year.
EPS Next Y12.98%
EPS Next 2Y32.97%
EPS Next 3Y26%
EPS Next 5YN/A
Revenue Next Year7.11%
Revenue Next 2Y6.48%
Revenue Next 3Y7.93%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ORP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
ORP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ORP is cheaper than 78.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.13 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ORP's earnings are expected to grow with 26.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.97%
EPS Next 3Y26%
5. Dividend
5.1 Amount
No dividends for ORP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ORPEA
EPA:ORP (4/23/2024, 1:44:12 PM)
12.954
+0.62 (+5.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.06B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.42% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.17 | ||
| Quick Ratio | 0.16 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-6733.33%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y12.98%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.89%
Revenue growth 3Y7.76%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y